tiprankstipranks
Trending News
More News >

Cellectar Biosciences Raises $2.5 Million via Stock Sale

Story Highlights
  • Cellectar Biosciences raised $2.5 million through common stock sale agreements.
  • The company exercised warrants for 8,301,322 shares at a reduced price for corporate purposes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cellectar Biosciences Raises $2.5 Million via Stock Sale

Elevate Your Investing Strategy:

Cellectar Biosciences ( (CLRB) ) just unveiled an update.

On June 5, 2025, Cellectar Biosciences entered into agreements to raise $2.5 million through the sale of common stock, with the closing expected around June 6, 2025. This transaction involves the immediate exercise of outstanding warrants for 8,301,322 shares at a reduced price, with proceeds intended for general corporate purposes.

The most recent analyst rating on (CLRB) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Cellectar Biosciences stock, see the CLRB Stock Forecast page.

Spark’s Take on CLRB Stock

According to Spark, TipRanks’ AI Analyst, CLRB is a Underperform.

Cellectar Biosciences faces significant financial challenges with no revenue generation and heavy reliance on external financing. Technical indicators suggest a bearish trend, and the company’s valuation is weakened by negative earnings. Although the earnings call highlighted some clinical and regulatory progress, these are overshadowed by financial and operational setbacks, leading to a below-average overall stock score.

To see Spark’s full report on CLRB stock, click here.

More about Cellectar Biosciences

Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery and development of proprietary drugs for cancer treatment. The company leverages its Phospholipid Drug Conjugate™ (PDC) delivery platform to develop targeted cancer therapies, including iopofosine I 131, CLR 121225, and CLR 121125, among others.

Average Trading Volume: 10,906,691

Technical Sentiment Signal: Sell

Current Market Cap: $12.79M

See more data about CLRB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1